Minimal residual disease in chronic myeloid leukaemia

Hematology and Cell Therapy

Volumn 40, Issue 5, 1998, Pages 224-228

  Cross, N C P ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; MESSENGER RNA;

ALLOGENIC BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CONFERENCE PAPER; HUMAN; LYMPHOCYTE TRANSFER; MINIMAL RESIDUAL DISEASE; QUANTITATIVE ASSAY; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BONE MARROW TRANSPLANTATION; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, MYELOID, CHRONIC; NEOPLASM, RESIDUAL; REMISSION INDUCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031772383     PISSN: 12693286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Hagemeijer A (1987) Chromosome abnormalities in CML. Baill Clin Haematol 1: 963-981
2. Lion T, Bartram CR, Talpaz M, et al (1996) Debate round table. Monitoring of residual disease in chronic myelogenous leukemia: methodological approaches and clinical aspects. Leukemia 10: 896-906
3. Cross NCP (1997) Assessing residual leukaemia. Baill Clin Haematol 10: 389-403
4. Clarkson B, Strife A (1993) Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment. Leukemia 7:1683-1721
5. Melo JV (1996) The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 88: 2375-2384
6. Lin F, Goldman JM, Cross NCP (1994) A comparison of the sensitivity of blood and bone marrow for the detection of minimal residual disease in chronic myeloid leukaemia. Br J Haematol 86: 683-685
7. Hochhaus A, Lin F, Reiter A, et al (1996) Quantification of residual disease in chronic myelogenous leukemia patients on interferon-a therapy by competitive polymerase chain reaction. Blood 87: 1549-1555
8. Miyamura K, Barrett AJ, Kodera Y, Saito H (1994) Minimal residual disease after bone marrow transplantation for chronic myelogenous leukemia and implications for graft-versus-leukemia effect: a review of recent results. Bone Marrow Transplant 14: 201-209
9. Miyamura K, Tahara T, Tanimoto M, et al (1993) Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients. Blood 81: 1089-1093
10. Cross NCP, Hughes TP, Feng L, et al (1993) Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse. Br J Haematol 84: 67-74
11. Roth MS, Antin JH, Ash R, et al (1992) Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia. Blood 79: 276-282
12. Radich JP, Gehly G, Gooley T, et al (1995) Polymerase chain-reaction detection of the bcr-abl fusion transcript after allogeneic marrow transplantation for chronic myeloid-leukemia - results and implications in 346 patients. Blood 85: 2632-2638
13. Pichert G, Roy DC, Gonin R, et al (1995) Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia. J Clin Oncol 13: 1704-1713
14. Hochhaus A, Lin F, Reiter A, et al (1995) Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon alpha. Br J Haematol 91: 126-131
15. Lion T, Henn T, Gaiger A, et al (1993) Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia. Lancet 341: 275-276
16. Cross NCP, Lin F, Chase A, et al (1993) Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 82: 1929-1936
17. Lin F, van Rhee F, Goldman JM, Cross NCP (1996) Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation . Blood 87: 4473-4478
18. van Rhee F, Lin F, Cullis JO, et al (1994) Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood 83: 3377-3383
19. Raanani P, Dazzi F, Sohal J, et al (1997) The rate and kinetics of molecular response to donor leukocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation. Br J Haematol 99: 945-950
20. Tchirkov A, Giollant M, Tavernier F, et al (1998) Interphase cytogenetics and competitive RT-PCR for residual disease monitoring in patients with chronic myeloid leukaemia during interferon-a therapy. Br J Haematol 101: 552-557
21. Reiter A, Marley SB, Hochhaus A, et al (1998) BCR-ABL positive primitive progenitors in chronic myeloid leukemia patients in complete cytogenetic remission after treatment with interferon-a. Br J Haematol: in press
22. Lin F, Kirkland MA, van Rhee F, et al (1996) Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant 18: 1147-1152